Date: June 16, 2022
Location: Online
Organised by: Phacilitate

Cell and gene therapies have had tremendous effects on the treatment of previously incurable diseases. Many products are already on the road to commercialization.

However, scaling complex manufacturing operations is still a challenge, and managing multiple concurrent workstreams is onerous and very manual. Each therapeutic developer needs to manage multiple factors/resources internally and externally to deliver a great customer and patient experience.

Join us as a panel of experts discusses key challenges in industrial manufacturing, supply chain management, patient operations, and order fulfillment. The panel of industry leaders will also share insights from their own experiences.

WHAT TO EXPECT

This 60-minute session will feature a short presentation with a session dedicated to an interactive panel discussion where you will be able to ask your questions.

Part 1: The panel addresses key challenges associated with scheduling and forecast allocation for advanced therapies, including:

  • Current state of industrial standard: how do companies manage complex internal and external operations?
  • Scheduling: what are the key challenges and processes for scheduling and re-scheduling batch manufacturing?
  • Slot allocation: minimizing impact on planned activities and how to manage exceptions/conflicts
  • Connected processes: challenges in managing a process that requires technical ops, QC, QA, facilities and other teams to be in-sync for manufacturing and releasing each batch
  • Optimization: how can we optimize this complex process? What lessons have the panel learnt?

Part 2: The panel answers audience questions with an interactive Q&A.

 

More info and registration: https://www.phacilitate.com/webinar-industrializing-next-generation-therapies-resource-optimization-customer-experience_binocs

 

 

No Comments

Sorry, the comment form is closed at this time.